LON:DXRX

Diaceutics Final Earnings Results & Report

Diaceutics logo
GBX 182 -8.00 (-4.21%)
As of 11/20/2026 12:33 PM Eastern

Diaceutics reported Final earnings on May 13, 2025. The company reported EPS of -GBX 2.02.

Earnings Announcement Details

Quarter
Final
Report Date
Time
Before Market Opens

Diaceutics EPS Results

Actual EPS
-GBX 2.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Diaceutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Diaceutics Final Earnings FAQ

Diaceutics (LON:DXRX) reported earnings of -GBX 2.02 per share for Final. The report was announced on Tuesday, May 13, 2025.

Diaceutics Earnings Headlines

Diaceutics (LON:DXRX) Stock: Insider Jordan Clark Sells 250,000 Shares
My $247 scanner for $7
Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel
Canaccord Genuity Group Reaffirms Buy Rating for Diaceutics (LON:DXRX)
Diaceutics (LON:DXRX) Stock Falls 1.4% - Here's Why
See More Diaceutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Diaceutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Diaceutics and other key companies, straight to your email.

About Diaceutics

At Diaceutics (LON:DXRX) we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.

View Diaceutics Profile